dallas semaglutide pancreatitis class action SURGE IN GLP-1 DRUGS LIKE OZEMPIC SPARKS THOUSANDS OF LAWSUITS OVER ALLEGED SIDE EFFECTS The medications, initially for type 2 diabetes, have driven widespread off-label weight-loss use amid reported gastrointestinal injuries and semaglutide pancreatitis class action in
Description
Cureus, 2021
Say goodbye to stubborn fat
This gradual approach helps distinguish between temporary adjustment symptoms and true intolerance
Anaemia B12 and folate deficiency
These gastrointestinal issues could be fatal without urgent medical attention
and 8.3% after 12 months
